Bionano Genomics, Inc.
BNGO
$4.00
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 34.41% | -21.85% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 34.41% | -21.85% | |||
| Cost of Revenue | -67.31% | 179.97% | |||
| Gross Profit | 140.46% | -426.73% | |||
| SG&A Expenses | -90.96% | -18.11% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -68.38% | 21.74% | |||
| Operating Income | 95.96% | -43.18% | |||
| Income Before Tax | 54.49% | -173.01% | |||
| Income Tax Expenses | -95.83% | -7.69% | |||
| Earnings from Continuing Operations | 54.52% | -172.72% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 54.52% | -172.72% | |||
| EBIT | 95.96% | -43.18% | |||
| EBITDA | 107.86% | -32.77% | |||
| EPS Basic | 60.47% | -114.64% | |||
| Normalized Basic EPS | 78.34% | 4.68% | |||
| EPS Diluted | 60.47% | -114.64% | |||
| Normalized Diluted EPS | 78.34% | 4.68% | |||
| Average Basic Shares Outstanding | 15.05% | 27.06% | |||
| Average Diluted Shares Outstanding | 15.05% | 27.06% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||